Published in Biotech Law Weekly, November 19th, 2004
The agreement will enable Zimmer to submit a request to U.S. and Canadian health officials for authorization to sell a ceramic-on-ceramic system, utilizing CeramTec-manufactured components, based on clinical reference data owned by CeramTec.
Zimmer has marketed for several years, outside of North America, a ceramic-on-ceramic system, the Trilogy AB...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.